Ticker
PRTACompany Name
PROTHENA CORP PUBLIC LTD COSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Capital Expenditures to Operating Cash Flow | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ 180K | 0% | $ -192.66M |
3/31/2025 | $ 237K | 0% | $ -130.36M |
12/31/2024 | $ 298K | 0% | $ -150.05M |
9/30/2024 | $ 1.77M | 0% | $ -153.32M |
6/30/2024 | $ 2.2M | 0% | $ -98.61M |
3/31/2024 | $ 2.83M | 0% | $ -159.5M |
12/31/2023 | $ 2.77M | 0% | $ -133.91M |
9/30/2023 | $ 1.41M | 0% | $ -87.84M |
6/30/2023 | $ 1.1M | 0% | $ -128.53M |
3/31/2023 | $ 490K | 0% | $ -118.86M |
CapEx / CF - Operations
(=) CapEx/OCF
CapEx/OCF for PROTHENA CORP PUBLIC LTD CO is calculated as follows: CapEx [ $ 251K ] / CF - Operations [ $ -75.76M ]
(=) CapEx/OCF [ 0% ]
Minimum
Sep 30, 2021
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 2.35K |
---|---|
min | 0.01% |
max | 128% |
average | 31.82% |
median | 22.41% |
std | 29.54% |